Why the study?
Does disruption of the Cav2.3 subunit impair glucose tolerance and insulin release in mice?
Does disruption of the Cav2.3 subunit impair glucose tolerance and insulin release in mice?
Deletion of the Cav2.3 calcium channel subunit in mice impairs insulin release and stress-induced hyperglycemia, demonstrating its critical role in endocrine function and glucose homeostasis.
Cav2.3 deletion impairs insulin release in mice; leaves open its role in human glucose homeostasis and therapeutic targeting.
Multiple types of voltage-activated Ca(2+) channels (T, L, N, P, Q, R type) coordinate Ca(2+)-dependent processes in neurons and neuroendocrine cells. Expressional and functional data have suggested a role for Ca(v)2.3 Ca(2+) channels in endocrine processes. To verify its role in vivo, Ca(v)2.3(-/-) mutant mice were generated, thus deficient in alpha 1E/R-type Ca(2+) channel. Intraperitoneal injection of D-glucose showed that glucose tolerance was markedly reduced, and insulin release into plasma was impaired in Ca(v)2.3-deficient mice. In isolated islets of Langerhans from these animals, no glucose-induced insulin release was detected. Further, in stressed Ca(v)2.3-deficient mice, the rate of glucose release into the blood was only 29% of that observed for wild-type animals. Thus, the deletion of Ca(v)2.3 causes deficits not only in insulin release but also in stress-induced hyperglycemia. The complex phenotype of Ca(v)2.3-deficient mice has dual components related to endocrine and neurological defects. The present findings provide direct evidence of a functional role for the Ca(v)2.3 subunit in hormone secretion and glucose homeostasis.
No takes yet. Share an insight, caveat, or question.
Pereverzev et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: